Leishmaniasis (Kala-Azar) Pipeline Review, H2 2012 New Report
Leishmaniasis (Kala-Azar) - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Leishmaniasis (Kala-Azar), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Leishmaniasis (Kala-Azar).
View full press release